Document is current
Any future updates will be listed below
-
Authors
Guo, Yaxun
Li, Yuzhan
Zhou, Zhongmei
Hou, Lei
Liu, Wenjing
Ren, Wenlong
Mi, Dazhao
Sun, Jian
Dai, Xueqin
Wu, Yingying
Cheng, Zhuo
Wu, Tingyue
Luo, Qianmei
Tian, Cong
Li, Fubing
Yu, Zhigang
Chen, Yihua
Chen, Ceshi https://orcid.org/0000-0001-6398-3516
-
Funding
Funding for this research was provided by:
National Key R&D Program of China (2020YFA0112300, 2023ZD0502200, 2023YFA1800403)
National Science Foundation of China (82060548, 82203878, 82302957)
National Science Foundation of China (U2102203)
National Science Foundation of China (82430084, 82072914, 82473762)
China Postdoctoral Science Foundation (2023M731011, 2023M731448)
Postdoctoral Fellowship Program of CPSF (GZC20240483)
Biomedical Projects of Yunnan Key Science and Technology Program (202302AA310046)
Biomedical Projects of Yunnan Key Science and Technology Program (202502AA310002)
Yunnan Provincial Department of Science and Technology (202101AY070001-083)
Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University (202401AY070001-026)
Yunnan Fundamental Research Projects (202401CF070054, 202201BC070002)
Yunnan Revitalization Talent Support Program (Yunnan Revitalization Talent Support Program)
Yunnan (Kunming) Academician Expert Workstation (Q7YSZJGZZ-2020025)
the Innovative Research Team of Yunnan Province (202405AS350016)
Regional Key R&D Program of Ningxia Hui Autonomous Region (2023BEG02010)
- License Information
-
More Information
Article History
Received: 21 October 2024
Accepted: 20 November 2024
First Online: 30 November 2024
Declarations
:
: The animal experiment followed the ARRIVE guidelines and had been approved by the Animal Ethics Committee of the Kunming Medical University (kmmu20240729). Additionally, the patient-derived organoids assays conformed the Declaration of Helsinki and had been approved by the Ethics Committee of Yunnan Cancer Hospital (KYCS2023-078).
: All the authors consent for publication.
: The authors declare no potential conflicts of interest.
